MedPath

Evluation of Thyroid Functions in Hemodialysis Childern in Sohag University Hospital

Not Applicable
Conditions
Chronic Renal Failure
Interventions
Diagnostic Test: thyroid function tests
Diagnostic Test: complete blood count
Diagnostic Test: serum creatinine
Diagnostic Test: blood urea
Diagnostic Test: serum electrolyte
Diagnostic Test: serum calcium
Diagnostic Test: serum phosphorus
Diagnostic Test: parathyroid hormone level
Diagnostic Test: liver function test
Diagnostic Test: arterial blood gases
Diagnostic Test: complete urine analysis
Registration Number
NCT05451472
Lead Sponsor
Sohag University
Brief Summary

Thyroid gland and its hormones play an important role in organ development and the homeostatic control of many physiological mechanisms such as body growth and energy expenditure. The two main thyroid hormones are triiodothyronine (T3) and thyroxine (T4) affect renal development and metabolism so any impairment in thyroid functions lead to or aggravate kidney diseases.

On the other hand, kidneys play an important role in the thyroid metabolism as it normally contributes to the clearance of iodide, primarily by glomerular filtration. Among patients with renal failure, there is diminished iodide excretion and an increase in plasma inorganic iodide, which results in increased uptake of the iodide by the thyroid gland. Increases in total body inorganic iodide can potentially block thyroid hormone production (the Wolff-Chaik off effect). Such a change may explain the slightly higher frequency of goiter and hypothyroidism in patients with chronic kidney diseases.

The kidneys affect the hypothalamic pituitary-thyroid axis, so any impairment in kidney functions leads to disturbed thyroid physiology. All levels of the hypothalamic-pituitary-thyroid axis may be involved, including alterations in hormone production, distribution, and excretion.

End stage renal disease (ESRD) and hemodialysis (HD) affect the levels of all thyroid hormones. The earliest and the most common thyroid function abnormality in patients with ESRD on HD is low T3 level (especially total T3 than free T3). This is called 'low T3 syndrome. The prevalence of subclinical hypothyroidism has been reported to be much higher in patients with ESRD on HD than in the general population.

Due to similarity of signs and symptoms, sometimes it is difficult to identify subjects with ESRD also has hypothyroidism; therefore, different studies have been carried out to establish the incidence of these conditions.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
39
Inclusion Criteria
  • Children started hemodialysis for end stage renal disease at age of 2 to 16 years will be included in the study.
Read More
Exclusion Criteria
  • Patients with known thyroid disease. Patients with a history of autoimmune disease .
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
pediatric groupserum electrolyte-
pediatric groupthyroid function tests-
pediatric groupcomplete blood count-
pediatric groupliver function test-
pediatric groupcomplete urine analysis-
pediatric groupblood urea-
pediatric groupserum phosphorus-
pediatric grouparterial blood gases-
pediatric groupserum creatinine-
pediatric groupserum calcium-
pediatric groupparathyroid hormone level-
Primary Outcome Measures
NameTimeMethod
Detection of thyroid function in hemodialysis childern6 months

Detection of decrease thyroid function(T3_T4_TSH) in hemodialysis childern Detection of increase thyroid function(T3_T4_TSH) in hemodialysis childern

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath